Nabla Bio secures $26m in Series A funding round
Pharmaceutical Technology
MAY 15, 2024
Nabla Bio has secured $26m in a Series A financing round led by Radical Ventures, for generative protein designing.
Wed.May 15, 2024
245 
Eisai sets new revenue target for Alzheimer’s drug Leqembi
Bio Pharma Dive
MAY 15, 2024
The annual forecast, which comes as Eisai and Biogen have begun submitting a more convenient form of Leqembi for approval, looks “more realistic” than previous guidance, according to Jefferies analysts.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA clears IND for Verismo Therapeutics’ CAR-T therapy
Pharmaceutical Technology
MAY 15, 2024
Verismo Therapeutics announced FDA clearance for a Phase I trial of its CAR-T therapy to treat non-Hodgkin lymphoma.
Scientists Reveal Just How Far Plastic Can Reach Into Your Lungs
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 15, 2024
Miniscule fragments of plastic pollution invade the human body every day without our knowing it, not just from eating and drinking but from simply breathing. By some estimates, the average person inhales a credit card’s worth of plastic every week with unknown health effects.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA rejects label expansion for Dynavax’s hepatitis B vaccine
Pharmaceutical Technology
MAY 15, 2024
The US agency rejected the expanded use of Dynavax’s vaccine for adults on haemodialysis, citing insufficient efficacy and safety data.
Blackstone-backed biotech launches with up to $300M for immune drug
Bio Pharma Dive
MAY 15, 2024
Uniquity Bio emerged from stealth mode ready to begin Phase 2 trials of an antibody targeting the protein TSLP in asthma and COPD.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Bolt Biotherapeutics to lay off staff, abandon lead ADC candidate
Bio Pharma Dive
MAY 15, 2024
The company will cut its workforce by half and shuffle leadership as it discontinues testing of the drug trastuzumab imbotolimod.
PCI issues guidelines for institutions prior to commencement of inspection process
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 15, 2024
The Pharmacy Council of India (PCI) has issued guidelines for the institutions related to the inspection process for the academic year 2024-25, mandating that the students and the faculties should have their smart cards and the infrastructure of the institutions should have mandatory active Quick Response (QR) code at the time of inspection.
Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
Bio Pharma Dive
MAY 15, 2024
The parent of Novo Nordisk is acquiring 60% ownership of Single Use Support. Elsewhere, ICER is raising questions about a PTSD drug and BioMarin is cut jobs after a pipeline review.
GLP-1 receptor agonist sales expected to reach $125bn by 2033
Pharmaceutical Technology
MAY 15, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of incretin mimetic medicines for the treatment of Type 2 diabetes and obesity.
May 15, 2024: This Week’s PCT Grand Rounds to Feature the CardioHealth Alliance
Rethinking Clinical Trials
MAY 15, 2024
Dr. Ken Mahaffey, Dr. Nishant Shah, and Dr. Neha Pagidipati In this Friday’s PCT Grand Rounds, Ken Mahaffey of Stanford University and Nishant Shah and Neha Pagidipati of Duke University will present “CardioHealth Alliance: A Platform to Improve Care.” The Grand Rounds session will be held on Friday, May 17, 2024, at 1:00 pm eastern.
Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised
Pharmaceutical Technology
MAY 15, 2024
CircRNA is still in early days of development, but could be in trials as vaccines, therapeutics and biomarkers in the next few years.
NIHR and TJBCM announce new funding initiative for novel brain tumour research
Pharma Times
MAY 15, 2024
The condition is the ninth most common cancer in the UK and affects 12,300 people annually
Eisai begins rolling submission to FDA for injectable version of Leqembi
Pharmaceutical Technology
MAY 15, 2024
Eisai has initiated a rolling submission to FDA for approval of a more convenient version of its Alzheimer’s disease treatment Leqembi.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
US study reveals interferon combinations cause lupus symptoms and affect treatment
Pharma Times
MAY 15, 2024
The autoimmune disease, which affects 1.
Companies prepare for ADC trial readouts at ASCO 2024
Pharmaceutical Technology
MAY 15, 2024
Several companies have announced data presentations at the 2024 ASCO annual meeting for their late-stage and approved programs.
With new partnership, Galapagos takes decentralized CAR-T manufacturing quest nationwide
Fierce Pharma
MAY 15, 2024
Though Galapagos has undergone plenty of staff shakeups and strategy revamps in recent years, the company is sticking strong to the CAR-T pivot first unveiled by CEO Paul Stoffels, M.D., following | Galapagos has teamed up with the largest blood supply network in the U.S. to help establish decentralized CAR-T production on a national scale.
OCT Europe: Unless everyone is benefiting, what is the point?
Pharmaceutical Technology
MAY 15, 2024
A big topic at Arena International’s Outsourcing in Clinical Trials Europe 2024 is how everyone should benefit from clinical research.
In Novo pricing probe, Sanders cranks up the heat with dire warning on projected GLP-1 spending
Fierce Pharma
MAY 15, 2024
After recently placing a spotlight on Novo Nordisk’s "outrageous" U.S. | A new Senate HELP Committee report says GLP-1 drugs could "bankrupt our entire health care system" because of their high prices coupled with high uptake.
Enveric Biosciences to out-license psilocin prodrug to MindBio
Pharmaceutical Technology
MAY 15, 2024
Enveric Biosciences has entered a non-binding term sheet with MindBio Therapeutics to out-license a class of psilocin prodrugs.
GSK, UK govt put £130m into antimicrobial resistance fight
pharmaphorum
MAY 15, 2024
GSK has become the first founding partner of the new Fleming Initiative, which aims to tackle the rising threat of antimicrobial resistance (AMR) and is also backed by the UK government.
University of Nottingham develops 3D-printed medication method
Pharmaceutical Technology
MAY 15, 2024
The University of Nottingham in the UK has announced the development of a new method enabling the creation of 3D-printed personalised pills.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Home testing devices for sleep apnoea backed for NHS use
pharmaphorum
MAY 15, 2024
Five home-testing devices to diagnose sleep apnoea, which can affect the health of around 2.5 million adults in the UK, have been recommended for NHS use by NICE.
Moffitt and Fulgent Pharma partner on personalised cancer therapies
Pharmaceutical Technology
MAY 15, 2024
Moffitt Cancer Center and Fulgent Pharma have announced a partnership to enhance the development of personalised therapies for cancer.
Eli Lilly settles with spa selling knockoff Mounjaro, Zepbound amid crackdown on fake GLP-1 meds
Fierce Pharma
MAY 15, 2024
After Eli Lilly sued several companies that were allegedly selling unauthorized versions of its tirzepatide products, the drugmaker has successfully cracked down on one of them. | Under legal pressure from Eli Lilly, a medical spa has agreed to pay an undisclosed settlement and undertake several "corrective actions," such as noting publicly that compounded versions of Lilly's tirzepatide products are not approved by the FDA.
Case Study: MHRA
pharmaphorum
MAY 15, 2024
MHRA's innovative regulatory approach enables Nuwiq's accelerated clinical trial timeline for haemophilia patients. Learn how their flexible approach is speeding access to new treatments.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Eisai predicts sharp Leqembi sales increase as launch efforts begin to bear fruit
Fierce Pharma
MAY 15, 2024
Reflecting on Eisai’s Alzheimer’s disease development journey—from Aricept’s U.S. | Eisai has laid out an ambitious goal to hit 56.5 billion yen (roughly $364 million) in global Leqembi sales for the 2024 fiscal year, which wraps up next March. Eisai banked its estimate on the fact that the company and its partner Biogen have steadily improved Alzheimer’s disease diagnosis and treatment pathways over the past year.
FDA clears BMS’ Breyanzi for follicular lymphoma
pharmaphorum
MAY 15, 2024
BMS gets another FDA approval for its CD19-directed CAR-T Breyanzi, this time as a third-line or later therapy for follicular lymphoma
LogiPharma Europe 2024: World Courier President Talks Mitigating Supply Chain Risks
Pharmaceutical Commerce
MAY 15, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno at LogiPharma Europe, Nick Porter, President, World Courier discusses mitigating supply chain risks, the future of artificial intelligence in pharma logistics, and more.
FDA clears Roche self-collection system for HPV screening
pharmaphorum
MAY 15, 2024
The FDA has approved Roche's HPV self-sampling solution that the company says can tackle unequal access to screening that can put women at risk of cervical cancer
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content